Cover Image
市場調查報告書

再生醫療的全球市場:各治療方法 (細胞療法,遺傳基因療法)、產品 (自我細胞/同種異體細胞/無細胞)、用途、地區的預測

Regenerative Medicine Market: By Therapy (Cell Therapy, Gene Therapy), By Product (Autologous Cell-Based, Allogeneic Cell-Based, Acellular), By Application (Orthopaedic & Musculoskeletal Spine, Dermatology) & By Region-Forecast (2016-2021)

出版商 IndustryARC 商品編碼 422454
出版日期 內容資訊 英文 136 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
再生醫療的全球市場:各治療方法 (細胞療法,遺傳基因療法)、產品 (自我細胞/同種異體細胞/無細胞)、用途、地區的預測 Regenerative Medicine Market: By Therapy (Cell Therapy, Gene Therapy), By Product (Autologous Cell-Based, Allogeneic Cell-Based, Acellular), By Application (Orthopaedic & Musculoskeletal Spine, Dermatology) & By Region-Forecast (2016-2021)
出版日期: 2016年09月19日 內容資訊: 英文 136 Pages
簡介

本報告提供全球再生醫療的相關市場相關分析,關於產品概要和整體市場結構,主要的推動及阻礙市場要素,各治療法、各產品、各用途、各地區的市場趨勢預測 (今後7年份),市場競爭概況,近來的資本交易、策略發展的動向,主要企業簡介等調查評估。

第1章 再生醫療:市場概況

第2章 摘要整理

第3章 市場環境

  • 市場佔有率分析
  • 比較分析
  • 產品的互相比較
  • 終端用戶簡介
  • 前五名公司的財務分析

第4章 再生醫療市場影響要素

  • 推動市場要素
  • 阻礙市場要素
  • 市場機會
  • 課題
  • 波特的五力分析

第5章 再生醫療市場:策略分析

  • 價值鏈分析
  • 價格趨勢分析
  • 市場機會分析
  • 產品/市場生命週期分析
  • 供應商、經銷商

第6章 再生醫療市場:各治療法

  • 細胞療法
  • 遺傳基因療法
  • 組織工程
  • 免疫療法

第7章 再生醫療市場:各產品

  • 自我細胞產品
  • 同種異體細胞產品
  • 無細胞產品

第8章 再生醫療市場:各用途

  • 整形外科、肌肉骨骼系統脊椎
  • 皮膚
  • 心血管
  • 中樞神經系統 (CNS)
  • 腫瘤
  • 糖尿病
  • 其他

第9章 再生醫療市場:各地區

  • 歐洲 (德國、法國、義大利、西班牙、俄羅斯、英國等)
  • 亞太地區 (中國、日本、印度、韓國等)
  • 北美 (美國、加拿大、墨西哥)
  • 其他的國家 (RoW) (巴西等)

第10章 再生醫療市場:市場變化的方向性

  • 產業擴張
  • 技術進步
  • 企業合併、收購 (M&A),合資企業
  • 供給契約

第11章 企業簡介

第12章 附錄

目錄

Regenerative medicines are capable of restoring the functionality of cells & tissues by treating a patient with laboratory grown cells and tissues. Regenerative medicines are used in a wide range of degenerative disorders such as dermatology, neurodegenerative diseases, cardiovascular and orthopaedic applications. Globally, development of efficient and advance technology in tissue and organ regeneration, growing funding from government and private organizations to support the development of regenerative medicines products, rise in the awareness among people regarding regenerative medicine, increasing government initiative across the globe, and growing aging population and healthcare expenditure are the prime growth drivers of global regenerative medicine market. In addition, Emergence of utilization of nanomaterial in wound care, drug delivery, and immunomodulation, increase in adoption of regenerative medicine for peripheral artery diseases, and emerging economies such as China, India and others, will create new opportunities for global regenerative medicine market. However, higher cost of the research and development, and complex government approval processes are the key restraints for global regenerative medicine market.

Geographically North America dominated global regenerative medicine market because of high medical reimbursement facilities, and technological advancement. Asia Pacific is projected to have fastest growth, owing to rapidly increasing aging population and per capita healthcare expenditure, rise in consumer awareness, higher focus on research in regenerative medicines especially in Japan, favourable government policies, modernization of healthcare infrastructure, and growing medical tourism industry in developing nations such as China, and India in this region. Among all the application, orthopaedic & musculoskeletal spine segment has the highest market share in global regenerative medicine market due to higher prevalence of musculoskeletal cases and growing investments in orthopaedic research.

This report identifies the global regenerative medicine market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the market drivers, restraints, growth indicators, challenges, and other key aspects with respect to global regenerative medicine market.

This report segments global regenerative medicine market on the basis of therapy, product, application, and regional market as follows:

Regenerative Medicine Market, By Therapy: Cell Therapy, Gene Therapy, Tissue Engineering, and Immunotherapy

Regenerative Medicine Market, By Product: Autologous Cell-Based Products, Allogeneic Cell-Based Products, and Acellular Products

The report has focused study on regenerative medicine market by basis of application such as: Orthopedic & Musculoskeletal Spine, Dermatology, Cardiovascular, Central Nervous System, Oncology, Diabetes, and Others

This report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region

This report identifies all the major companies operating in the regenerative medicine market. Some of the major companies' profiles in detail are as follows:

Japan Tissue Engineering Co., Ltd

Vertex Pharmaceuticals Incorporated

Cytori Therapeutics Inc.

Celgene Corporation

Acelity (KCI Licensing)

Table of Contents

1. Regenerative Medicine Market - Market Overview

2. Executive Summary

3. Market Landscape

  • 3.1. Market Share Analysis
  • 3.2. Comparative Analysis
  • 3.3. Product Benchmarking
  • 3.4. End User Profiling
  • 3.5. Top 5 Financials Analysis

4. Regenerative Medicine Market- Market Forces

  • 4.1. Drivers
    • 4.1.1. Development of efficient and advance technology in tissue and organ regeneration
    • 4.1.2. Growing funding from government and private organizations to support the development of regenerative medicines products
  • 4.2. Restraints
    • 4.2.1. Higher cost of research and development
  • 4.3. Opportunities
    • 4.3.1. Emerging economies
  • 4.4. Challenges
  • 4.5. Porter's Five Forces Analysis
    • 4.5.1. Bargaining Power of Suppliers
    • 4.5.2. Bargaining Power of Buyers
    • 4.5.3. Threat of New Entrants
    • 4.5.4. Threat of Substitutes
    • 4.5.5. Degree of Competition

5. Regenerative Medicine Market- Strategic Analysis

  • 5.1. Value Chain Analysis
  • 5.2. Pricing Analysis
  • 5.3. Opportunities Analysis
  • 5.4. Product/Market Life Cycle Analysis
  • 5.5. Suppliers and Distributors

6. Regenerative Medicine Market, By Therapy

  • 6.1. Cell Therapy
  • 6.2. Gene Therapy
  • 6.3. Tissue Engineering
  • 6.4. Immunotherapy

7. Regenerative Medicine Market, By Product

  • 7.1. Autologous Cell-Based Products
  • 7.2. Allogeneic Cell-Based Products
  • 7.3. Acellular Products

8. Regenerative Medicine Market, By Application

  • 8.1. Orthopedic & Musculoskeletal Spine
  • 8.2. Dermatology
  • 8.3. Cardiovascular
  • 8.4. Central Nervous System
  • 8.5. Oncology
  • 8.6. Diabetes
  • 8.7. Others

9. Regenerative Medicine Market, By Geography

  • 9.1. Europe
    • 9.1.1. Germany
    • 9.1.2. France
    • 9.1.3. Italy
    • 9.1.4. Spain
    • 9.1.5. Russia
    • 9.1.6. U.K.
    • 9.1.7. Rest of Europe
  • 9.2. Asia Pacific
    • 9.2.1. China
    • 9.2.2. India
    • 9.2.3. Japan
    • 9.2.4. South Korea
    • 9.2.5. Rest of Asia-Pacific
  • 9.3. North America
    • 9.3.1. U.S.
    • 9.3.2. Canada
    • 9.3.3. Mexico
  • 9.4. Rest of the World (RoW)
    • 9.4.1. Brazil
    • 9.4.2. Rest of RoW

10. Regenerative Medicine - Market Entropy

  • 10.1. Expansion
  • 10.2. Technological Developments
  • 10.3. Merger & Acquisitions, and Joint Ventures
  • 10.4. Supply- Contract

11. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)

  • 11.1. Japan Tissue Engineering Co., Ltd
  • 11.2. Vertex Pharmaceuticals Incorporated
  • 11.3. Cytori Therapeutics Inc.
  • 11.4. Celgene Corporation
  • 11.5. Acelity (KCI Licensing)
  • 11.6. Nuvasive, Inc.
  • 11.7. Organogenesis Inc.
  • 11.8. Vericel Corporation
  • 11.9. Cytori Therapeutics Inc.
  • 11.10. Stemcells, Inc.

More than 40 Companies are profiled in this Research Report, Complete List available on Request*

"*Financials would be provided on a best efforts basis for private companies"

12. Appendix

  • 12.1. Abbreviations
  • 12.2. Sources
  • 12.3. Research Methodology
  • 12.4. Bibliography
  • 12.5. Compilation of Expert Insights
  • 12.6. Disclaimer
Back to Top